An exclusive Tech Tribune Q&A with Newton Howard (founder and CEO) of ni2o, which was honored in our:
Tell us the origin story of ni2o – what problem were you trying to solve and why?
Currently, it is estimated that more than 50 million people worldwide live with a degenerative neurological disease, and that is expected to more than triple by 2050. Global costs associated with these diseases today are in excess of US $1 trillion dollars annually. As a lifelong learner and a neuroscientist, as well as both a father and son, the global health crisis resonates with me on a deeply personal level. I believe it is my responsibility to utilize my abilities to help ease suffering and restore dignity to those suffering from degenerative neurological diseases, so that is what I am doing.
What was the biggest hurdle you encountered in your journey?
The development of feasible and workable solutions has outpaced health policy and regulation, as well as social acceptance.
What does the future hold for ni2o?
We anticipate ni2o to revolutionize and overturn the stagnant condition of individualized treatment by utilizing AI and next generation technologies to provide more effective, efficient, and palatable solutions.
What are your thoughts on the local tech startup scene in Providence?
Providence has seen great growth in the tech startup space, and with increased infrastructure and funding from angels and VCs, I believe much more significant growth is possible.
What’s your best advice for aspiring entrepreneurs?
Believe in your idea. Don’t take no for an answer, especially from engineers, but know when to be flexible and take advice to improve the overall product and company while staying true to your vision. Last but not least, be patient. It’s a marathon, a long one, and you will need endurance for the entire race.